What results to disclose, when, and who decides? Healthcare professionals' views on prenatal chromosomal microarray analysis

Prenatal Diagnosis

Volumn 36, Issue 3, 2016, Pages 252-259

  Shkedi Rafid, Shiri ^a   Fenwick, Angela ^a   Dheensa, Sandi ^a   Wellesley, Diana ^b   Lucassen, Anneke M ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME ANALYSIS; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INFORMATION DISSEMINATION; MALE; METHODOLOGY; MICROARRAY ANALYSIS; PARENT; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; UNITED KINGDOM; ADULT; CHROMOSOME DISORDERS; DECISION MAKING; HEALTH PERSONNEL ATTITUDE; INTERPERSONAL COMMUNICATION; ONSET AGE; PRENATAL DIAGNOSIS; PROCEDURES; PROFESSIONAL-PATIENT RELATIONSHIP; PSYCHOLOGY; QUESTIONNAIRE; TIME FACTOR; UNCERTAINTY;

ADULT; AGE OF ONSET; ATTITUDE OF HEALTH PERSONNEL; CHOICE BEHAVIOR; CHROMOSOME DISORDERS; DISCLOSURE; FEMALE; HUMANS; MALE; MICROARRAY ANALYSIS; PREGNANCY; PRENATAL DIAGNOSIS; PROFESSIONAL-PATIENT RELATIONS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; UNCERTAINTY;

EID: 84975763680     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4772     Document Type: Article

References (38)

1. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010;86:749-64.
2. Ahn JW, Bint S, Bergbaum A, et al. Array CGH as a first line diagnostic test in place of karyotyping for postnatal referrals-results from four years' clinical application for over 8, 700 patients. Mol Cytogenet 2013;6:10-16.
3. Vanakker O, Vilain C, Janssens K, et al. Implementation of genomic arrays in prenatal diagnosis: the Belgian approach to meet the challenges. Eur J Med Genet 2014;57:151-6.
4. Obstetricians ACo, Gynecologists. Committee opinion no. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol 2013;122:1374-7.
5. Hillman S, McMullan D, Hall G, et al. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol 2013;41:610-20.
6. Rosenfeld JA, Coe BP, Eichler EE, et al. Estimates of penetrance for recurrent pathogenic copy-number variations. Genet Med 2012;15:478-81.
7. Armengol L, Nevado J, Serra-Juhé C, et al. Clinical utility of chromosomal microarray analysis in invasive prenatal diagnosis. Hum Genet 2012;131:513-23.
8. Cavalli P, Cavallari U, Novelli A. Array CGH in routine prenatal diagnosis practice. Prenat Diagn 2012;32:708-9.
9. Pichert G, Mohammed SN, Ahn JW, et al. Unexpected findings in cancer predisposition genes detected by array comparative genomic hybridisation: what are the issues? J Med Genet 2011;48:535-9.
10. Bernhardt BA, Kellom K, Barbarese A, et al. An exploration of genetic counselors' needs and experiences with prenatal chromosomal microarray testing. J Genet Couns 2014;23:938-47.
11. Mikhaelian M, Veach PM, MacFarlane I, et al. Prenatal chromosomal microarray analysis: a survey of prenatal genetic counselors' experiences and attitudes. Prenat Diagn 2013;33:371-7.
12. Walser SA, Kellom KS, Palmer SC, Bernhardt BA. Comparing genetic counselor's and patient's perceptions of needs in prenatal chromosomal microarray testing. Prenat Diagn 2015;35:870-8.
13. Dziopa F, Ahern K. A systematic literature review of the applications of Q-technique and its methodology. Meth: Eur J Res Meth Behav Soc Sci 2011;7:39-55.
14. Stephenson W. The Study of Behavior; Q-Technique and its Methodology. The University of Chicago Press: Chicago; 1953.
15. Ahmed S, Bryant LD, Tizro Z, Shickle D. Interpretations of informed choice in antenatal screening: a cross-cultural, Q-methodology study. Soc Sci Med 2012;74:997-1004.
16. Kelly SE, Farrimond HR. Non-invasive prenatal genetic testing: a study of public attitudes. Public Health Genomics 2012;15:73-81.
17. Farrimond HR, Kelly SE. Public viewpoints on new non-invasive prenatal genetic tests. Publ Understand Sci 2013;22:730-44.
18. Wright KF, Bryant LD, Morley S, et al. Presenting life with cystic fibrosis: a Q-methodological approach to developing balanced, experience-based prenatal screening information. Health Expect 2015;18(5):1349-62. DOI:10.1111/hex.12113.
19. Rogers RS. Q methodology. In Rethinking Methods in Psychology, Smith JA, Harre R, Langenhove LV (eds). SAGE Publication Ltd: London, 1995;178-92.
20. EACH study. Available at: http://www.nets.nihr.ac.uk/__data/assets/pdf_file/0010/55468/PRO-10-60-03.pdf [Accessed on 1 December 2015].
21. The Joint Committee on Genomics in Medicine (JCGM). 2015. Recommendations for the use of chromosome microarray in pregnancy. Available at: http://www.bsgm.org.uk/media/956141/g144_useofcmapregnancy_jun15.pdf [Accessed on January 2016].
22. Genethics Club. Available at: www.genethicsclub.org [Accessed on 1 December 2015].
23. Bernhardt BA, Soucier D, Hanson K, et al. Women's experiences receiving abnormal prenatal chromosomal microarray testing results. Genet Med 2012;15:139-45.
24. Van der Steen S, Diderich K, Riedijk S, et al. Pregnant couples at increased risk for common aneuploidies choose maximal information from invasive genetic testing. Clin Genet 2014;88:25-31.
25. Srebniak M, Boter M, Oudesluijs G, et al. Application of SNP array for rapid prenatal diagnosis: implementation, genetic counselling and diagnostic flow. Eur J Hum Genet 2011;19:1230-7.
26. Kalynchuk EJ, Althouse A, Parker LS, et al. Prenatal whole exome sequencing: parental attitudes. Prenat Diag 2015; e-pub ahead of print 17 June 2015. DOI:10.1002/pd.4635.
27. Hillman SC, Skelton J, Quinlan-Jones E, et al. "If it helps..." the use of microarray technology in prenatal testing: patient and partners reflections. Am J Med Genet A 2013;161:1619-27.
28. Wellesley DG, Lucassen A. Prenatal diagnosis of chromosomal imbalances. Arch Dis Child Fetal Neonatal Ed 2014;99:F338-41.
29. Genetics ACoOaGCo. Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol 2013;122:1374-7.
30. Novelli A, Grati F, Ballarati L, et al. Microarray application in prenatal diagnosis: a position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU), November 2011. Ultrasound Obstet Gynecol 2012;39:384-8.
31. Fiorentino F, Baldi M. Re: Microarray application in prenatal diagnosis: a position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU), November 2011. Ultrasound Obstet Gynecol 2012;39:601-2.
32. Fiorentino F, Napoletano S, Caiazzo F, et al. Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities. Eur J Hum Genet 2012;21:725-30.
33. Kitzman JO, Snyder MW, Ventura M, et al. Noninvasive whole-genome sequencing of a human fetus. Sci Trans Med 2012;4:137ra76.
34. Srinivasan A, Bianchi DW, Huang H, et al. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013;92:167-76.
35. van Schendel RV, Kleinveld JH, Dondorp WJ, et al. Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening. Eur J Hum Genet 2014;22:1345-50.
36. Bennett CL, Burke SE, Burton H, Farndon PA. A toolkit for incorporating genetics into mainstream medical services: learning from service development pilots in England. BMC Health Serv Res 2010;10:125.
37. Vetro A, Bouman K, Hastings R, et al. The introduction of arrays in prenatal diagnosis: a special challenge. Hum Mutat 2012;33:923-9.
38. Scott F, Murphy K, Carey L, et al. Prenatal diagnosis using combined quantitative fluorescent polymerase chain reaction and array comparative genomic hybridization analysis as a first-line test: results from over 1000 consecutive cases. Ultrasound Obstet Gynecol 2013;41:500-7.